Nariman K. Badr El-Din

639 total citations
25 papers, 514 citations indexed

About

Nariman K. Badr El-Din is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nariman K. Badr El-Din has authored 25 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nariman K. Badr El-Din's work include Cell death mechanisms and regulation (5 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer-related Molecular Pathways (4 papers). Nariman K. Badr El-Din is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer-related Molecular Pathways (4 papers). Nariman K. Badr El-Din collaborates with scholars based in Egypt, United States and Saudi Arabia. Nariman K. Badr El-Din's co-authors include Mamdooh Ghoneum, Eman Noaman, Doaa A. Ali, Lorna Tolentino, Deyu Pan, Stanley T. Omaye, Sameh M. Shabana, Amina E. Essawy, Ashraf M. Abdel‐Moneim and Samuel W. French and has published in prestigious journals such as Cancer Research, European Journal of Cancer and Cancer Letters.

In The Last Decade

Nariman K. Badr El-Din

24 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nariman K. Badr El-Din Egypt 15 182 110 64 63 60 25 514
Wanisa Punfa Thailand 14 262 1.4× 93 0.8× 50 0.8× 128 2.0× 64 1.1× 23 619
Kotteazeth Srikumar India 14 221 1.2× 146 1.3× 43 0.7× 25 0.4× 50 0.8× 51 634
Zhen Cheng China 15 249 1.4× 71 0.6× 30 0.5× 125 2.0× 43 0.7× 48 621
Eun‐Sook Yoo South Korea 14 170 0.9× 55 0.5× 44 0.7× 39 0.6× 35 0.6× 21 570
Nurul Husna Shafie Malaysia 12 234 1.3× 86 0.8× 19 0.3× 45 0.7× 68 1.1× 34 527
Gökçe Taner Türkiye 16 109 0.6× 120 1.1× 28 0.4× 67 1.1× 24 0.4× 33 575
June‐Ki Kim South Korea 14 296 1.6× 126 1.1× 22 0.3× 87 1.4× 53 0.9× 20 661
Mustafa Zeyadi Saudi Arabia 13 170 0.9× 94 0.9× 29 0.5× 29 0.5× 66 1.1× 48 496

Countries citing papers authored by Nariman K. Badr El-Din

Since Specialization
Citations

This map shows the geographic impact of Nariman K. Badr El-Din's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nariman K. Badr El-Din with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nariman K. Badr El-Din more than expected).

Fields of papers citing papers by Nariman K. Badr El-Din

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nariman K. Badr El-Din. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nariman K. Badr El-Din. The network helps show where Nariman K. Badr El-Din may publish in the future.

Co-authorship network of co-authors of Nariman K. Badr El-Din

This figure shows the co-authorship network connecting the top 25 collaborators of Nariman K. Badr El-Din. A scholar is included among the top collaborators of Nariman K. Badr El-Din based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nariman K. Badr El-Din. Nariman K. Badr El-Din is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghoneum, Mamdooh, et al.. (2024). Anti-radiation effect of MRN-100: a hydro-ferrate fluid, in vivo. Journal of Radiation Research. 65(2). 145–158. 1 indexed citations
2.
El-Din, Nariman K. Badr, et al.. (2022). Thymax, a gross thymic extract, exerts cell cycle arrest and apoptosis in Ehrlich ascites carcinoma in vivo. Heliyon. 8(3). e09047–e09047. 4 indexed citations
3.
El-Din, Nariman K. Badr, et al.. (2020). A novel kefir product (PFT) inhibits Ehrlich ascites carcinoma in mice via induction of apoptosis and immunomodulation*. BMC Complementary Medicine and Therapies. 20(1). 127–127. 24 indexed citations
4.
El-Din, Nariman K. Badr, et al.. (2020). Chemopreventive role of arabinoxylan rice bran, MGN-3/Biobran, on liver carcinogenesis in rats. Biomedicine & Pharmacotherapy. 126. 110064–110064. 23 indexed citations
5.
El-Din, Nariman K. Badr, et al.. (2018). Grape seeds and skin induce tumor growth inhibition via G1-phase arrest and apoptosis in mice inoculated with Ehrlich ascites carcinoma. Nutrition. 58. 100–109. 22 indexed citations
6.
El-Din, Nariman K. Badr, et al.. (2017). Abstract 5004: Chemopreventive potential of Lactobacillus kefiri P-IF, a novel kefir product, on Ehrlich ascites carcinoma cells. Cancer Research. 77(13_Supplement). 5004–5004. 1 indexed citations
7.
El-Din, Nariman K. Badr, et al.. (2016). Abstract 5259: Prevention of hepatocarcinogenesis in rats by arabinoxylan rice bran, MGN-3/Biobran. Cancer Research. 76(14_Supplement). 5259–5259. 4 indexed citations
8.
El-Din, Nariman K. Badr, et al.. (2016). Enhancing the Apoptotic Effect of a Low Dose of Paclitaxel on Tumor Cells in Mice by Arabinoxylan Rice Bran (MGN-3/Biobran)*. Nutrition and Cancer. 68(6). 1010–1020. 20 indexed citations
9.
Ghoneum, Mamdooh, et al.. (2015). Hydroferrate Fluid, MRN-100, Provides Protection against Chemical-Induced Gastric and Esophageal Cancer in Wistar Rats. International Journal of Biological Sciences. 11(3). 295–303. 14 indexed citations
10.
El-Din, Nariman K. Badr, et al.. (2015). Abstract 5312: Biobran/MGN-3, arabinoxylan from rice bran, sensitizes breast adenocarcinoma tumor cells to paclitaxol in mice. Cancer Research. 75(15_Supplement). 5312–5312. 2 indexed citations
11.
Ghoneum, Mamdooh, et al.. (2014). Modified arabinoxylan from rice bran, MGN-3/biobran, sensitizes metastatic breast cancer cells to paclitaxel in vitro.. PubMed. 34(1). 81–7. 35 indexed citations
12.
Abdel‐Moneim, Ashraf M., et al.. (2013). Biochemical and histopathological changes in liver of the Nile tilapia from Egyptian polluted lakes. Toxicology and Industrial Health. 32(3). 457–467. 20 indexed citations
13.
Ghoneum, Mamdooh, et al.. (2013). Arabinoxylan rice bran (MGN-3/Biobran) provides protection against whole-body  -irradiation in mice via restoration of hematopoietic tissues. Journal of Radiation Research. 54(3). 419–429. 35 indexed citations
14.
Amin, Ali H., Soo Kyoung Choi, Nariman K. Badr El-Din, et al.. (2012). Sodium nitrite therapy rescues ischemia-induced neovascularization and blood flow recovery in hypertension. Pflügers Archiv - European Journal of Physiology. 464(6). 583–592. 15 indexed citations
16.
El-Din, Nariman K. Badr, Eman Noaman, & Mamdooh Ghoneum. (2008). In Vivo Tumor Inhibitory Effects of Nutritional Rice Bran Supplement MGN-3/Biobran on Ehrlich Carcinoma-Bearing Mice. Nutrition and Cancer. 60(2). 235–244. 55 indexed citations
18.
El-Din, Nariman K. Badr & Stanley T. Omaye. (2007). Concentration‐dependent antioxidant activities of conjugated linoleic acid and α‐tocopherol in corn oil. Journal of the Science of Food and Agriculture. 87(14). 2715–2720. 11 indexed citations
19.
Ghoneum, Mamdooh, et al.. (2007). Saccharomyces cerevisiae, the Baker’s Yeast, suppresses the growth of Ehrlich carcinoma-bearing mice. Cancer Immunology Immunotherapy. 57(4). 581–592. 31 indexed citations
20.
El-Din, Nariman K. Badr. (2004). Protective role of sanumgerman against γ-irradiation–induced oxidative stress in Ehrlich carcinoma-bearing mice. Nutrition Research. 24(4). 271–291. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026